3rd Quarter - Termination

HOSPIRA, INC. for HOSPIRA INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$270,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Sep 2, 2015

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Termination (this page) Aug 31, 2015 $270,000 Replaced
3rd Quarter - Termination Amendment Jan 20, 2016 $180,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 1137-Protecting American Talent and Entrepreneurship Act of 2015

LobbyistCovered position, as disclosed
JULIANA REED —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1137 (114th)

Health Issues HCR

Implementation of the Biologics Price Competition and Innovation Act (BPCIA); CMS Proposed Rule {CMS-1631-P} RIN 0938-AS40 - Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2016

LobbyistCovered position, as disclosed
JULIANA REED —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)

LobbyistCovered position, as disclosed
JULIANA REED —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Science/Technology SCI

Issues relating to medical product cybersecurity

LobbyistCovered position, as disclosed
JULIANA REED —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.